<DOC>
	<DOCNO>NCT00335439</DOCNO>
	<brief_summary>The study evaluate efficacy prophylactic administration topical nonsteroidal anti-inflammatory drug ( NSAID ) ketorolac tromethamine 0.5 % ( AcularÂ® ) cystoid macular edema ( CME ) patient undergone cataract surgery . CME frequent cause decrease vision uncomplicated cataract surgery result irreversible sight reduction . The investigation involve comparison arm treatment arm set patient population evaluate CME ophthalmologic examination optical coherence tomography ( OCT ) measurement . The objective elucidate role NSAID drop prevent CME cataract surgery .</brief_summary>
	<brief_title>Effect Prophylactic Ketorolac CME After Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Capsule Opacification</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>First cataract surgery ( i.e. , first eye ) . hypersensitivity NSAID drug class , pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>